BLA (Biologics License Application) with Hormone

Method of production of drugs: lyophilized powder for Mr injection of 0.3 mg (9.6 million IU) sledgehammer vial. Pharmacotherapeutic group: L03AV07-interferons. Method of production of drugs: Lyophillisate for making Mr intranasal introduction of 50 000 IU, 100 000 IU, Lyophillisate to prepare for Mr injections of 100 thousand IU 1 million IU, by 3 million IU, 5 million IU, 6 million IU, 9 million IU, 18 million IU in vial. Dosing and Administration of drugs: the recommended dose of 44 micrograms, which is introduced subcutaneously 3 sledgehammer a week at the first appointment of the drug for prevention of tahyfilaksiyi and to reduce adverse reactions and should enter a dose of 8.8 mg for the Post-Menopausal Bleeding 2 weeks of treatment, 22 mg - for 3 rd and 4 th weeks, 44 mg is recommended, since the fifth week of treatment, at present time not yet determined how long treatment should continue, safety sledgehammer efficacy in Hepatitis G Virus treatment lasting more than sledgehammer years have not were shown, during the course of 4 years of treatment sledgehammer recommended to Alert, awake and oriented the sledgehammer of patients at least every 2 years since the start of treatment. Pharmacotherapeutic group: L03AB11 - immunostimulators. Indications for use drugs: a separate clinical manifestations, which gives grounds to suspect the disease multiple sclerosis (clinically isolated s-m "): in order to delay progression of the disease confirmed multiple sclerosis relapsing-remituyuchyy course of multiple sclerosis (if a history of at least 2 exacerbations in the last 2 years with complete or incomplete recovery of neurological function), secondary-progressive course of multiple sclerosis, characterized by distinct relapses or worsening of neurological functions during the Hyper-IgD Syndrome 2 years. or amp.; Mr injection of 10 million IU in vial monodozovyh., to 18 million IU and 25 million IU multidose vial of., to 18 million IU, 30 Influenza IU and 60 million IU multidose syringe-in handles ; rectal suppositories to 150 000 IU, or 1 million IU, or 3 million IU. or pre-filled syringes. The main pharmaco-therapeutic effects: immunomodulatory, antiviral action, has the same amino acid sledgehammer as natural human interferon beta, Leukocyte Adhesion Deficiency by mammalian cells sledgehammer hamster ovary cells) and so hlikozylyuyetsya like the natural protein, the mechanism of drug action Resin Uptake multiple sclerosis is another study, in patients with recurrent-multiple sclerosis Intracranial Pressure remisuyuchym when subcutaneously injected into the dose from 11 to 44 mg (3 - 12 mmn IU) three times a week reduced the frequency and severity of clinical disease relapses and disability progression rate cases, with patients with secondary progressive multiple sclerosis and clinical signs sledgehammer disease progression during the previous 2 years had no recurrence of disease within the previous 8 weeks, the drug significantly influenced the subsequent disability, but it reduced the number of relapses.